Congress Trades

Coverage gap. Senate eFD: the last 13 checks failed; last successful check Oct 23. New filings from this source are not coming in. Newest Senate eFD filing on this site: 2026-10-21.

Source status

TECHBio-Techne Corporation

Healthcare · BiotechnologyNasdaqStockMkt cap $11.3B
Disclosed trades
39
0 in 30d · 0 in 90d
Politicians
5
Last trade Jun 30, 2026
Buys
18
$144K at range midpoints
Sells
20
$184.5K at range midpoints

Closing price · 365 days

Nov 6, 2025 – Nov 5, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

1 hold it now Estimated
Politicians who traded TECH
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last tradeEst. position Estimated
DRo KhannaHouse · CA-17241211$96K$112.5KJun 30, 2026$37.7K
DApril McClain DelaneyHouse · MD-061156$40K$48KApr 8, 2026—
RRobert P. Bresnahan, Jr.House · PA-08211$8K$8KApr 8, 2025—
RGreg GianforteHouse · MT-00101$0$8KOct 13, 2020—
DJulie JohnsonHouse · TX-32101$0$8KApr 1, 2025—

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountvs S&P EstimatedTradedFiledSource
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellSpouse$1,001 - $15,000-4.9%Jun 30, 2026Jul 6, 20266dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellReviewUnknown$1,001 - $15,000-4.9%Jun 2, 2026Jul 6, 202634dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuySpouse$1,001 - $15,000+34.1%May 15, 2026Jun 9, 202625dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNUnknownReviewSelf$1,001 - $15,000—Apr 13, 2026May 11, 202628dFilingOCR
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)SellDependent$1,001 - $15,000-53.4%Apr 8, 2026May 6, 202628dFiling
DRo KhannaTECHBIO TECHNE CORPORATION CMNBuyDependent$1,001 - $15,000+23.8%Mar 30, 2026Apr 7, 20268dFilingOCR
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)PartialDependent$1,001 - $15,000-23.8%Mar 26, 2026Apr 6, 202611dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)PartialDependent$1,001 - $15,000-29.3%Feb 24, 2026Mar 10, 202614dFiling
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuySpouse$1,001 - $15,000+2.7%Jan 29, 2026Feb 6, 20268dFilingOCR
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)PartialDependent$1,001 - $15,000-6.0%Jan 28, 2026Feb 2, 20265dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)BuyDependent$1,001 - $15,000+8.7%Dec 5, 2025Jan 5, 202631dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)BuyDependent$1,001 - $15,000+8.7%Dec 2, 2025Jan 5, 202634dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)BuyDependent$1,001 - $15,000+10.4%Oct 22, 2025Nov 4, 202513dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)PartialDependent$1,001 - $15,000-21.5%Aug 1, 2025Sep 2, 202532dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)PartialDependent$1,001 - $15,000-18.5%May 26, 2025Jul 2, 202537dFiling
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuySpouse$1,001 - $15,000+19.8%May 28, 2025Jun 10, 202513dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuyDependent$1,001 - $15,000+19.8%May 19, 2025Jun 10, 202522dFilingOCR
DJulie JohnsonTECHBio-Techne Corp - Common Stock (TECH)SellJoint$1,001 - $15,000-27.1%Apr 1, 2025May 14, 202543dFiling
RRobert P. Bresnahan, Jr.TECHBio-Techne Corp - Common Stock (TECH)SellSelf$1,001 - $15,000-16.2%Apr 8, 2025May 8, 202530dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)BuyDependent$1,001 - $15,000+14.6%Apr 29, 2025May 2, 20253dFiling
DApril McClain DelaneyTECHBio-Techne Corp - Common Stock (TECH)BuyDependent$1,001 - $15,000+14.6%Apr 9, 2025May 2, 202523dFiling
RRobert P. Bresnahan, Jr.TECHBio-Techne Corp - Common Stock (TECH)BuySelf$1,001 - $15,000-8.1%Feb 25, 2025Mar 27, 202530dFiling
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellReviewDependent$15,001 - $50,000+13.4%Feb 25, 2025Mar 6, 20259dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellSpouse$1,001 - $15,000+13.4%Feb 19, 2025Mar 6, 202515dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuyReviewSpouse$1,001 - $15,000-27.7%Feb 16, 2024Jan 8, 2025327dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuyDependent$1,001 - $15,000-22.5%Nov 15, 2024Dec 5, 202420dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuyReviewDependent$1,001 - $15,000——Nov 8, 2024FilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellSpouse$1,001 - $15,000+38.9%Jul 1, 2024Aug 7, 202437dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuySpouse$1,001 - $15,000-45.4%May 28, 2024Jun 5, 20248dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuyDependent$1,001 - $15,000-56.5%Dec 5, 2023Jan 4, 202430dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellDependent$1,001 - $15,000+51.2%Nov 3, 2023Dec 6, 202333dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNBuyDependent$1,001 - $15,000-43.8%Oct 2, 2023Nov 8, 202337dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellDependent$1,001 - $15,000+79.0%Jun 26, 2023Jul 11, 202315dFilingOCR
DRo KhannaTECHBIO-TECHNE CORPORATION CMNSellSpouse$1,001 - $15,000+88.5%Feb 14, 2023Mar 3, 202317dFilingOCR
DRo KhannaTECHBIo TEchNe corP CmnBuySpouse$1,001 - $15,000-96.0%Nov 3, 2022Dec 6, 202233dFilingOCR
DRo KhannaTECHBIO TECHNE CORP CMNPartialSpouse$1,001 - $15,000+101.2%May 23, 2022Jun 10, 202218dFilingOCR
DRo KhannaTECHBIO TECHNE CORP CMNSellDependent$1,001 - $15,000+101.2%May 10, 2022Jun 10, 202231dFilingOCR
DRo KhannaTECHBIO TECHNE CORP CMNPartialDependent$1,001 - $15,000+101.2%May 5, 2022Jun 10, 202236dFilingOCR
RGreg GianforteTECHbio-Techne Corp (TECH)PartialJoint$1,001 - $15,000+111.2%Oct 13, 2020Nov 9, 202027dFiling

Insider activity Filed

Insiders
15
Biological Products, (No Diagnostic Substances)
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
0
$0 sold
Net · 90d
$0
-$437.2K net over 12 months · last Nov 1, 2026
Insider transactions as filed on SEC Form 4
DateInsiderKindSecuritySharesPriceValuePost-holdingsD/I10b5-1Source
Nov 1, 2026filed Nov 3, 2026Kim KeldermanChief Executive OfficerWithholdingCommon Stock−2,385$72.66$173,29480,509D—4
Nov 1, 2026filed Nov 3, 2026James HippelCFOExerciseRestricted Stock Unitsderiv.−11,545$0.00—11,544D—4
Nov 1, 2026filed Nov 3, 2026James HippelCFOWithholdingCommon Stock−5,096$72.66$370,275176,720D—4
Nov 1, 2026filed Nov 3, 2026James HippelCFOExerciseCommon Stock11,545$0.00$0181,816D—4
Oct 29, 2026filed Nov 2, 2026Rupert VesseyAwardCommon Stock2,750$0.00$013,737D—4
Oct 29, 2026filed Nov 2, 2026Alpna SethAwardCommon Stock2,750$0.00$018,161D—4
Oct 29, 2026filed Nov 2, 2026Judith V. KlimovskyAwardCommon Stock2,750$0.00$06,532D—4
Oct 29, 2026filed Nov 2, 2026Amy E. HerrAwardCommon Stock2,750$0.00$05,430D—4
Oct 29, 2026filed Nov 2, 2026Joseph D KeeganAwardCommon Stock2,750$0.00$018,161D—4
Oct 29, 2026filed Nov 2, 2026John L HigginsAwardCommon Stock2,750$0.00$080,004D—4

Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).

Unusual activity Estimated